IP Library Granted Patent US 9,890,193
Granted Patent B2
US 9,890,193 · App. 14/956,723 · Granted Feb 13, 2018

Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereof

Inventors: Shi-Qi Peng (Beijing, CN); Ming Zhao (Beijing, CN); Jian-Hui Wu (Beijing, CN); Yu-Ji Wang (Beijing, CN); Qi-Qi Feng (Beijing, CN)
Assignee: Shanghai Lumosa Therapeutics Co., Ltd.
C07K5/0821A61K47/545A61K47/55C07D217/00C07K5/0215C07K5/06165C07K5/1019A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,890,193
App. No.
14/956,723
Granted
Feb 13, 2018
Kind
B2
Abstract

The present invention relates to a compound simultaneously having triple activities of thrombolysis, antithrombosis and free radical scavenging, as well as the preparation method, composition, and applications thereof. The compound is represented by the formula I shown below: wherein the definitions of T, Q, R 1 and R 2 are described herein. The compound of the present invention simultaneously has triple functions of thrombolysis, free radical scavenging and thrombus-targeting/antithrombosis. The present invention also relates to a pharmaceutical composition comprising the compound, and a preparation method and a nanostructure of the compound.

Claims (7)

1. A compound having the following formula of Ia:

wherein AA is selected from the group consisting of L-Ala, L-Val, L-Trp, L-Tyr, L-Pro, L-Phe, Gly, L-Ser, L-Ile, L-Thr, L-Lys, L-Leu, L-Gln, L-Asn, L-Asp, and L-Glu.

2. The compound of claim 1 , wherein AA is L-Lys.

3. A pharmaceutical composition, comprising the compound of claim 1 , and a pharmaceutically acceptable carrier.

4. The pharmaceutical composition of claim 3 , wherein the compound is in the form of a nanospherical structure.

5. A method for performing thrombolysis, NO free radical scavenging or antithrombotic therapy in a subject in need thereof, the method comprising administering to the subject a pharmaceutically effective amount of the pharmaceutical composition of claim 3 .

6. A method of treating stroke or cerebral infarction, the method comprising administering to a subject in need thereof a pharmaceutically effective amount of the pharmaceutical composition of claim 3 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2015
From: PENG, SHI-QI; ZHAO, MING; WU, JIAN-HUI; WANG, YU-JI; FENG, QI-QI
To: YONG GUANG PHARMACEUTICAL CO., LTD.
Reel/Frame 037193/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2015
From: YONG GUANG PHARMACEUTICAL CO., LTD.
To: SHANGHAI LUMOSA THERAPEUTICS CO., LTD.
Reel/Frame 037193/0361 →
Priority Claims (1)
CN 2013 1 0225330 · Jun 5, 2013 · national
Continuity (2)
Continuation PCTCN2014079098 · Jun 3, 2014
Related Publication 20160083423A1 · Mar 24, 2016